FDA Issues Tougher Warning on MRI Gadolinium-Based Dye Tied to Brain Effects

TUESDAY, Dec. 19, 2017 — The U.S. Food and Drug Administration on Tuesday called for tougher warnings and “additional research” into a dye commonly used with standard MRIs.
The dye — a “contrast agent” — contains a metal called gadolinium. It…
Source: Topamax